Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07166601 |
| Title | M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors (TITER) |
| Acronym | TITER |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | EMD Serono Research & Development Institute, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Yale University School of Medicine | NOT_YET_RECRUITING | New Haven | Connecticut | 06510 | United States | Details |
| Icahn School of Medicine at Mount Sinai | NOT_YET_RECRUITING | New York | New York | 10029 | United States | Details |
| NEXT Oncology | RECRUITING | San Antonio | Texas | 78249 | United States | Details |
| Princess Margaret Cancer Centre | NOT_YET_RECRUITING | Toronto | Canada | Details | ||
| National Cancer Center Hospital | RECRUITING | Chūōku | Japan | Details |